Eureka Therapeutics Competitors and Similar CompaniesClear all
Eureka Therapeutics's competitors and similar companies include Immatics, Viralytics and Lion TCR.
 Eureka Therapeutics Eureka Therapeutics is a biotechnology company focused on discovery of novel antibody immunotherapies for the treatment of cancer.
|  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Viralytics Viralytics is a biotechnology company focused on the development and commercialization of oncology immunotherapies. |  Lion TCR Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases. | |
Founding Date | Founding Date 2006 | Founding Date N/A | Founding Date 2006 | Founding Date N/A |
Type | Type Private | Type Public | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Emeryville, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Sydney, AU HQ | Locations Singapore, SG HQ Guangzhou, CN Singapore, SG Singapore, SG |
Employees | Employees 46 | Employees 24215% increase | Employees N/A | Employees N/A |
Funding | ||||
Latest funding round | Latest funding round $ 45m (about 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 20m (almost 7 years ago) |
Total funding raised | Total funding raised $ 130.4m | Total funding raised $ 267.3m | Total funding raised $ 27m | Total funding raised $ 20m |
For sources of this data, please see the company profile
View Company Profiles
Immatics
HQ
Tübingen, DE
Employees
242↑ 15% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View companyViralytics
HQ
Sydney, AU
Viralytics is a biotechnology company focused on the development and commercialization of oncology immunotherapies.
View companyLion TCR
HQ
Singapore, SG
Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases.
View company